Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Serial Amnioinfusions With Isotonic Fluid

Research Leaders

5 sponsors active, led by Johns Hopkins University

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03101891Phase 1Completed

Renal Anhydramnios Fetal Therapy

NCT06728228Not ApplicableRecruiting

Amnioinfusion for Fetal Renal Failure

Showing all 2 trials

Research Network

Common Treatments

  • Serial Amnioinfusions With Isotonic Fluid1
  • Amnioinfusion1
  • Spinal Needle1
  • Isotonic Fluid1

Active Sponsors

  • Johns Hopkins University1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Fetal Care Center, PLLC1
  • Medical City Children's Hospital1
  • Medical City Women's Hospital1

Top Investigators

Related Conditions

  • Fetal Renal Anomaly2
  • Multicystic Dysplastic Kidney2
  • Lung Hypoplasia2
  • Multicystic Renal Dysplasia Bilateral2
  • Anhydramnios2

Activity Timeline